Precipio, Inc.

Precipio is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our products and services deliver higher accuracy, improved laboratory workflow, and ultimately better patient outcomes, which reduce healthcare expenses. Precipio develops innovative technologies in our laboratory where we design, test, validate, and use these products clinically, improving diagnostic outcomes. Precipio then commercializes these technologies as proprietary products that serve the global laboratory community and further scales Precipio’s reach to eradicate misdiagnosis.

Current securities

1. Results of Operations and Financial ConditionAug 14, 2026
2. 10-Q filingAug 14, 2026
3. Regulation FD DisclosureJul 31, 2026
4. Submission of Matters to a Vote of Security HoldersJun 15, 2026
5. 144 filingMay 19, 2026